# Efficacy of Stellate Ganglion Block in Dysphagic Patients With Bulbar Palsy After Ischemic Stroke

> **NCT06225076** · NA · WITHDRAWN · sponsor: **Zeng Changhao**

## Conditions studied

- Bulbar Palsy

## Interventions

- **BEHAVIORAL:** Comprehensive rehabilitation
- **PROCEDURE:** Stellate ganglion block
- **DRUG:** Lidocaine Hydrochloride

## Key facts

- **NCT ID:** NCT06225076
- **Lead sponsor:** Zeng Changhao
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-01-30
- **Primary completion:** 2024-04-15
- **Final completion:** 2024-05-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** ethical issues
- **Last updated:** 2024-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06225076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06225076, "Efficacy of Stellate Ganglion Block in Dysphagic Patients With Bulbar Palsy After Ischemic Stroke". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06225076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*